GHIPP x JSIE Regional Crises management and Leadership


We are facing various crises of global pandemic including COVID-19, Russia’s war, geopolitical changes, economic crises, and regional security threat. Preconditions have changed drastically, and we are at a critical juncture to fundamentally reconsider policies and framework to deal with such crises. We need to address appropriate resources and policies, through building resilient global communities and knowledge-based resource hubs. GHIPP is strengthening global partnership by building discussion platforms and sharing knowledge, lessons learned, and vision by creating new regional communities for resilience.

GHIPP Crisis Simulation Workshops

第1回 Crisis Simulation Workshop 詳細・レポート
第2回 Crisis Simulation Workshop   詳細・レポート
第3回 Crisis Simulation Workshop   詳細・レポート
第4回 Crisis Simulation Workshop   詳細・レポート

★プロジェクト・リーダー Project Leaders

村上 博美   Hiromi Murakami, Ph.D.


Hiromi Murakami is a senior fellow at Economic Strategy Institute and a visiting scholar at National Graduate Institute for Policy Studies. Previously, she’s involved in various policy projects in US/Japanese institutions, including Center for Strategic and International Studies (CSIS), the Health and Global Policy Institute, Economic Strategy Institute, and SAIS Johns Hopkins University. Her expertise includes state-industrial relations, public policy, and global health policies. Murakami is also an Adjunct professor at Temple University Japan. She holds an MBA in international business, and a Ph.D. in international relations from the School of Advanced International Studies at the Johns Hopkins University.

Selected articles include Hiromi Murakami. A Japan divided over COVID-19 control. The Strategist, Australian Strategic Policy Institute, March 9, 2020, Hiromi Murakami and Kiyoshi Kurokawa. “Disruptive Innovation and multi-stakeholder alliances” Health: A political choice, p78-80
黒川清   Kiyoshi Kurokawa, M.D. 

政策研究大学院大学名誉教授。東京大学医学部卒。1969-84年在米、UCLA医学部内科教授、東京大学医学部内科教授、東海大学医学部長、日本学術会議会長 (2003-06年), 内閣府総合科学技術会議議員(03-06年), 内閣特別顧問 (06-08年), WHOコミッショナー(05-09年)などを歴任。国会による東京電力福島原発事故調査委員会委員長 (11-12年), グローバルヘルス技術振興基金(GHIT Fund)代表理事・会長(13-18年), 内閣官房健康・医療戦略室健康・医療戦略参与(13-19年)など。現在、世界認知症審議会(WDC: World Dementia Council)委員・副議長、新型コロナウイルス対策の効果を検証する国のAIアドバイザリー・ボードの委員長、東京大学名誉教授。東海大学特別栄誉教授。

Dr. Kiyoshi Kurokawa is a graduate of the University of Tokyo Faculty of Medicine. From 1969 to 1984, he lived in the United States where he served as Professor of Internal Medicine at the University of California, Los Angeles (UCLA) School of Medicine. His other positions have included Professor of Internal Medicine, University of Tokyo; Dean, School of Medicine, Tokai University; President, Science Council of Japan (2003-2006); Member, Council for Science and Technology Policy, Cabinet Office (2003-2006); Special Advisor, Cabinet Office (2006-2008); and Commissioner, World Health Organization (WHO) (2005-2009). He also served as Chairman of the National Diet of Japan’s Fukushima Nuclear Accident Independent Investigation Commission (December 2011-July 2012), Chair and Representative Director of the Global Health Innovative Technology Fund (GHIT Fund) (January 2013-June 2018), and as Special Advisor on Health and Medical Strategy at the Cabinet Secretariat Headquarters for Healthcare and Medical Strategy Promotion (2013-2019).